Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.43
+1.32 (5.97%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Arcus Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
2,9372,9481,3631,4301,4972,843
Upgrade
Market Cap Growth
160.07%116.38%-4.70%-4.52%-47.33%68.68%
Upgrade
Enterprise Value
2,1482,2393516235682,367
Upgrade
Last Close Price
22.1123.8314.8919.1020.6840.47
Upgrade
PE Ratio
-----53.64
Upgrade
PS Ratio
11.9011.945.2812.2213.377.42
Upgrade
PB Ratio
4.394.672.813.102.283.38
Upgrade
P/TBV Ratio
4.664.672.813.102.283.38
Upgrade
P/FCF Ratio
----3.47-
Upgrade
P/OCF Ratio
----3.42-
Upgrade
EV/Sales Ratio
8.709.071.365.325.076.18
Upgrade
EV/EBITDA Ratio
-----40.82
Upgrade
EV/EBIT Ratio
-----43.84
Upgrade
EV/FCF Ratio
----1.31-
Upgrade
Debt / Equity Ratio
0.350.350.370.300.180.14
Upgrade
Debt / EBITDA Ratio
-----1.80
Upgrade
Debt / FCF Ratio
----0.28-
Upgrade
Net Debt / Equity Ratio
-1.25-1.25-1.67-1.57-1.55-0.67
Upgrade
Net Debt / EBITDA Ratio
2.102.102.712.193.72-9.72
Upgrade
Net Debt / FCF Ratio
1.631.634.612.20-2.362.00
Upgrade
Asset Turnover
0.220.220.230.100.080.32
Upgrade
Quick Ratio
4.324.324.444.355.457.51
Upgrade
Current Ratio
4.364.364.504.525.537.60
Upgrade
Return on Equity (ROE)
-63.26%-63.26%-59.77%-54.87%-35.62%7.89%
Upgrade
Return on Assets (ROA)
-21.08%-21.08%-17.26%-17.42%-11.92%2.85%
Upgrade
Return on Invested Capital (ROIC)
-----245.61%41.81%
Upgrade
Return on Capital Employed (ROCE)
-42.50%-42.50%-33.50%-37.30%-24.30%3.80%
Upgrade
Earnings Yield
-12.01%-11.97%-20.77%-21.47%-17.83%1.86%
Upgrade
FCF Yield
-16.47%-16.41%-12.92%-23.08%28.85%-9.92%
Upgrade
Buyback Yield / Dilution
-19.20%-19.20%-21.76%-2.78%2.70%-35.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.